BlackRock, Inc.

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 2012383 New York, NY

Position in SRPT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$341,339,386

+$20,264,568 QoQ

Shares Held

18,994,958

+28.7% QoQ

Ownership

18.0%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 323 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,603,777,939 across 474 Biotechnology names. SRPT ranks #54 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$299,067,881	16,642,620	—	Shares	Sole	2026-07-30
2026-06-30	$341,339,386	18,994,958	+28.7%	Shares	Sole	2026-08-07
2026-03-31	$321,074,818	14,755,277	+3.3%	Shares	Sole	2026-05-13
2025-12-31	$307,375,597	14,283,253	+8.2%	Shares	Sole	2026-02-12
2025-09-30	$254,361,006	13,199,845	+9.0%	Shares	Sole	2025-11-12
2025-06-30	$207,170,291	12,115,222	+22.3%	Shares	Sole	2025-08-12
2025-03-31	$632,256,306	9,906,868	-11.5%	Shares	Sole	2025-05-02
2024-12-31	$1,360,833,569	11,191,986	+1.5%	Shares	Sole	2025-02-07
2024-09-30	$1,376,701,676	11,023,314	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.